Profile
Mark Heiman worked as a Principal at Eli Lilly & Co. and as an Assistant Professor at Tulane University.
He was also the Chief Scientific Officer & Vice President-Research at MicroBiome Therapeutics LLC from 2013 to 2018.
He received his undergraduate degree from the University of New Orleans and his doctorate from LSU Medical School.
Former positions of Mark Heiman
| Companies | Position | End |
|---|---|---|
MicroBiome Therapeutics LLC
 MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Chief Tech/Sci/R&D Officer | 02/01/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| Tulane University (Louisiana) | Corporate Officer/Principal | - |
Training of Mark Heiman
| University of New Orleans | Undergraduate Degree |
| Lsu Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 1 |
|---|---|
MicroBiome Therapeutics LLC
MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Health Technology |
- Stock Market
- Insiders
- Mark Heiman
